DRUG COMPANY ASKS SUPREME COURT TO HOLD OFF ON REVIEW OF FCA ISSUES Purdue Pharma v. United States | Secondary Sources | Westlaw

DRUG COMPANY ASKS SUPREME COURT TO HOLD OFF ON REVIEW OF FCA ISSUES Purdue Pharma v. United States | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, DRUG COMPANY ASKS SUPREME COURT TO HOLD OFF ON REVIEW OF FCA ISSUES Purdue Pharma v. United States, Secondary Sources
Skip Page Header

DRUG COMPANY ASKS SUPREME COURT TO HOLD OFF ON REVIEW OF FCA ISSUES Purdue Pharma v. United States

21 No. 18 WJINTPROP 20Westlaw Journal Intellectual Property (Approx. 4 pages)

DRUG COMPANY ASKS SUPREME COURT TO HOLD OFF ON REVIEW OF FCA ISSUES Purdue Pharma v. United States

21 No. 18 WJINTPROP 20Westlaw Journal Intellectual Property (Approx. 4 pages)

21 No. 18 Westlaw Journal Intellectual Property 20
Westlaw Journal Intellectual Property
*1 December 24, 2014
Health Care Fraud
Copyright © 2014 Thomson Reuters .

DRUG COMPANY ASKS SUPREME COURT TO HOLD OFF ON REVIEW OF FCA ISSUES

Purdue Pharma v. United States

Briefs and Other Related Documents
A pharmaceutical company has asked the U.S. Supreme Court to hold its certiorari petition seeking review of an appeals court's decision on two False Claims Act issues until the high court rules in a pending, unrelated case.
Purdue Pharma LP et al. v....
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.